Marketwatch Piramal Pharma completes 20% stake sale to Carlyle Admin October 6, 2020 The transaction values the Pharma Business at an enterprise value of USD 2,775 million (over Rs 20,300 crore) with an upside component of up to USD 360 million (over Rs 2,630 crore) depending on the company’s FY21 performance, it added. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
